Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Masterclass on The Global Burden of CV Disease in Women
Author(s): Birgit Vogel , Harriette Van Spall Added: 2 years ago
In the ESC Congress 2021 episode of the Masterclass video series, host, Dr Harriette Van Spall (McMaster University, CA) meets with Dr Birgit Vogel (Icahn School of Medicine at Mount Sinai, US), one of the commissioners and first author of the "The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030" report.Dr Vogel talks about the rationale of the report. CV… View more

Demographic

Standards & Guidelines
TRILUMINATE Pivotal Trial Results
Author(s): Paul Sorajja , Ralph Stephan von Bardeleben , , et al Added: 1 year ago
In this short series of interviews, our faculty discuss the recent TRILUMINATE Pivotal Trial Results. We hear fromone of the lead PI’s on the trial,Dr Paul Sorajja (Abbott Northwestern Hospital, Minneapolis, US), as well as Cardiac Surgeon Dr Vinod Thourani (Piedmont Healthcare, Atlanta, US), Interventionalist Prof Ralph Stephan Von Bardeleben (Heart Valve Centre, Mainz, DE) and Heart… View more

Intervention
Heart Failure and Aortic Stenosis - What TAVI Can Offer
Author(s): Victoria Delgado , Jose Luis Zamorano , Davide Capodanno , et al Added: 1 year ago
In this video series, first presented at the ESC Congress 2022, held in Barcelona, Prof Ralph Stephan von Bardeleben, Prof Jose LuisZamorano, Dr Victoria Delgado, Prof DavideCapodanno and Dr SashaKoul discuss the diagnosis of low flow/low gradient aortic stenosis, which patients gain the most benefit from TAVI and how to avoid heart failure in aortic stenosis patients. Join this international… View more

Imaging & Diagnostics

Heart Failure
Distinguished Lecture: Heart Recovery – Insights from RESTAGE-HF
Author(s): Emma Birks Added: 1 year ago

Heart Failure
Author(s): Brian G Hynes , Thomas J Kiernan , Nicholas J Ruggiero , et al Added: 3 years ago
Stroke-related morbidity and mortality remain unacceptably high. Recent estimates suggest that it accounts for approximately one out of every 17 deaths in the US, and that a person dies from the direct consequences of stroke every three to four minutes.1 Of the almost 800,000 strokes that occur annually, 87% are ischaemic, the remainder occurring predominantly as a consequence of intracerebral… View more

Intervention
Author(s): Mamas A Mamas , Farzin Fath-Ordoubadi Added: 3 years ago
Bifurcation lesions account for 15–20% of all percutaneous coronary intervention (PCI) cases performed, representing about half a million cases annually.1 But PCI treatment for bifurcation coronary disease has historically yielded less satisfactory results than conventional stenting. The procedure is often technically challenging and has been associated with both lower procedural success rates… View more

Prevention & Chronic Conditions
Impella Support and Cardiac Gene Therapy for Heart Failure
Author(s): Roger J Hajjar Added: 6 years ago

Heart Failure
Post-CABG Management of Occlusive CAD
Author(s): Mohammed Shamim Rahman , Ruben de Winter , Alex Nap , et al Added: 2 years ago

Imaging & Diagnostics

Intervention
Author(s): Samir R Kapadia , Stephen G Ellis , Nyal Borges Added: 3 years ago
Obstructive unprotected left main coronary artery (ULMCA) disease has been recognised as a high-risk condition since the 1960s owing to the large quantum of myocardium supplied by this system (see Figure 1). In that era, medical therapy was the only available management and 5-year mortality rates exceeded 60 %.1 With the introduction of coronary artery bypass grafting (CABG) it became clear that… View more

Electrophysiology & Arrhythmia

Intervention
Author(s): Aman Ali , Timothy A Sanborn Added: 3 years ago
Cardiogenic shock (CS) remains the leading cause of death among patients hospitalised for acute myocardial infarction (AMI), with mortality rates of approximately 50%.1 Even with the benefit of thrombolytic therapy and intra-aortic balloon pumps (IABPs), the in-hospital mortality rate of patients with CS from AMI was only lowered from 63 to 47% according to a report from the SHould we emergently… View more

Anticoagulation

Heart Failure